Evidence map›Paper›PMID 37835198›Full record

ArticleFoods (Basel, Switzerland)2023

Evaluation of Microbial Dynamics of Kombucha Consortia upon Continuous Backslopping in Coffee and Orange Juice.

Maret Andreson, Jekaterina Kazantseva, Esther Malv, Rain Kuldjärv, Reimo Priidik, Mary-Liis Kütt

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maret AndresonCenter of Food and Fermentation Technologies, Mäealuse 2/4, 12618 Tallinn, Estonia.ORCID 0000-0002-6373-6205
Jekaterina KazantsevaCenter of Food and Fermentation Technologies, Mäealuse 2/4, 12618 Tallinn, Estonia.ORCID 0000-0001-6108-5499
Esther MalvCenter of Food and Fermentation Technologies, Mäealuse 2/4, 12618 Tallinn, Estonia.
Rain KuldjärvCenter of Food and Fermentation Technologies, Mäealuse 2/4, 12618 Tallinn, Estonia.ORCID 0000-0001-5759-4557
Reimo PriidikCenter of Food and Fermentation Technologies, Mäealuse 2/4, 12618 Tallinn, Estonia.ORCID 0000-0001-8937-0507
Mary-Liis KüttCenter of Food and Fermentation Technologies, Mäealuse 2/4, 12618 Tallinn, Estonia.

Funding

European Regional Development Fund 2014-2020.4.02.19-0228
6 · The paper itself

Abstract

The kombucha market is diverse, and competitors constantly test new components and flavours to satisfy customers' expectations. Replacing the original brewing base, adding flavours, or using "backslopping" influence the composition of the symbiotic starter culture of bacteria and yeast (SCOBY). Yet, deep characterisation of microbial and chemical changes in kombucha consortia in coffee and orange juice during backslopping has not been implemented. This study aimed to develop new kombucha beverages in less-conventional matrices and characterise their microbiota. We studied the chemical properties and microbial growth dynamics of lactic-acid-bacteria-tailored (LAB-tailored) kombucha culture by 16S rRNA next-generation sequencing in coffee and orange juice during a backslopping process that spanned five cycles, each lasting two to four days. The backslopping changed the culture composition and accelerated the fermentation. This study gives an overview of the pros and cons of backslopping technology for the production of kombucha-based beverages. Based on research conducted using two different media, this work provides valuable information regarding the aspects to consider when using the backslopping method to produce novel kombucha drinks, as well as identifying the main drawbacks that need to be addressed.

Indexed as

backsloppingcoffeefermented beveragekombuchalactic acid bacteriametagenomic analysisorange juice

Identifiers

PMID37835198
PMCPMC10572523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.